Corvus Pharmaceuticals CRVS
$ 9.05
1.23%
Quarterly report 2024-Q3
added 11-12-2024
Corvus Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CRVS
Annual EV/EBITDA Ratio Corvus Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
0.244 | -2.16 | -3.24 | -1.41 | -2.6 | -5.74 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.244 | -5.74 | -2.49 |